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Abstract
Background: TWEAK (Tumor necrosis factor like WEAK inducer of apoptosis) is highly expressed by different immune cells
and triggers multiple cellular responses, including control of angiogenesis. Our objective was to investigate its role in the
human endometrium during the implantation window, using an ex-vivo endometrial microhistoculture model. Indeed,
previous results suggested that basic TWEAK expression influences the IL-18 related uNK recruitment and local cytotoxicity.
Methodology/Principal Findings: Endometrial biopsies were performed 7 to 9 days after the ovulation surge of women in
monitored natural cycles. Biopsies were cut in micro-pieces and cultured on collagen sponge with appropriate medium.
Morphology, functionality and cell death were analysed at different time of the culture. We used this ex vivo model to study
mRNA expressions of NKp46 (a uNK cytotoxic receptor) and TGF-beta1 (protein which regulates uNK cytokine production)
after adjunction of excess of recombinant IL-18 and either recombinant TWEAK or its antibody. NKp46 protein expression
was also detailed by immunohistochemistry in selected patients with high basic mRNA level of IL-18 and either low or high
mRNA level of TWEAK. The NKp46 immunostaining was stronger in patients with an IL-18 over-expression and a low TWEAK
expression, when compared with patients with both IL-18 and TWEAK high expressions. We did not observe any difference
for TWEAK expression when recombinant protein IL-18 or its antibody was added, or conversely, for IL-18 expression when
TWEAK or its antibody was added in the culture medium. In a pro-inflammatory environment (obtained by an excess of IL-
18), inhibition of TWEAK was able to increase significantly NKp46 and TGF-beta1 mRNA expressions.
Conclusions/Significance: TWEAK doesn’t act on IL-18 expression but seems to control IL-18 related cytotoxicity on uNK
cells when IL-18 is over-expressed. Thus, TWEAK appears as a crucial physiological modulator to prevent endometrial uNK
cytotoxicity in human.
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Introduction
The endometrium is remodelled throughout the menstrual cycle
and exhibits only a short period of receptivity, known as the
‘implantation window’, which is crucial both for implantation and
gestation and still remains poorly explored in routine reproductive
medicine. Endometrium becomes receptive to blastocyst implan-
tation 6 to 8 days after ovulation and remains receptive for 4 days
(cycle days 20–24) [1]. Such differentiation of the maternal
compartment, under hormonal control, is essential to allow
stromal cells to acquire the unique ability to regulate trophoblast
invasion, to resist inflammatory and oxidative insults, and to
dampen local maternal immune response. In humans, deciduali-
zation of the stromal compartment occurs in the mid-luteal phase
of the menstrual cycle, independently of pregnancy, in contrast to
most of animal models. This raises the possibility that biochemical
analysis of timed endometrial biopsy samples taken in a
nonconception cycle could be informative of subsequent pregnan-
cy outcome [2].
It has been proposed that uterine natural killer cells (uNK) could
exert, directly or not, a positive or negative control of the early
steps of implantation [3], [4]. These cells can secrete and control
an array of cytokines which are important in angiogenesis,
placental development and in pregnancy establishment. A
dysregulation of these cytokines could be in part responsible of
embryo implantation failures. In previous studies, we reported that
IL-15 and IL-18 expressions were significantly different in patients
who failed to implant when compared with fertile control
individuals [5]. We also observed that IL-15 and IL-18 expressions
were correlated with the local uNK (CD56+) recruitment and
subendometrial angiogenesis as reflected by the vascular flow
index quantified by 3-D ultrasound with angiography [6].
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apoptosis) is a transmembrane protein, which can be cleaved to
function as a soluble cytokine [7]. It’s highly expressed by immune
cells type (monocytes, dendritic cells, natural killers cells…) and
many tissues [8].
First described as a weak apoptosis inducer, TWEAK triggers
multiple cellular responses [9] ranging from proliferation to cell
death, including control of angiogenesis [10], [11,12]. TWEAK
has also been described as a partner to TNF (Tumor Necrosis
Factor) playing a « Yin and Yang » function in immunity [13].
We recently reported that TWEAK and IL-18 mRNA
expression were correlated in patients with implantation failures
[14]. Therefore we investigated whether TWEAK regulates IL-18
expression or at the opposite if IL-18 acts on TWEAK expression.
TWEAK mRNA and protein expression does not show variations
through the menstrual cycle.
However its basal level of expression influence the IL-18 related
uNK recruitment and local cytotoxicity. Indeed, IL-18 is a
bivalent cytokine which can promote local angiogenesis and
immunotrophism at appropriate dose but conversely promote a
cytotoxic and thus deleterious commitment of uNK cells if present
in excess [5]. Such documentation appears to be essential to define
the state of uterine receptivity.
Endometrial dispersed cells cannot be used to document the in
vivo environment since this technique does not maintain the
interactions between epithelial cells, stromal cells, endothelials cells
and immune cells (uterine natural killer cells, T regulatory cells
and dendritic cells). The development of a human ex vivo model in
which the complexicity of endometrium is preserved as well as its
functionality is an absolute requirement. In order to study stromal-
epithelial interactions in the human endometrium, many authors
elaborated culture conditions recombining separated stromal and
epithelial cells in different extracellular matrices [15,16,17,18]. In
such models, epithelial cells have been cultivated as monolayers on
top of matrigel and stromal cells beneath them on plastic or
embedded in collagen or Matrigel. Other methods were described
using polycarbonate or nitrocellulose culture of tissue insert
[19,20] and demonstrated human epithelial and stromal cells
were viable during 1 to 5 days. In all these models, cells viability
was demonstrated but neither of them appears fully appropriate to
study the expression and production of cytokines or growth factors
in endometrial cells as well as to mimick the complexicity of their
interactions with immune and endothelials cells.
We thus decided to develop a model of endometrial micro-
histoculture, adapted from the one elaborated by Menu et al [21]
for the placenta, in which the complex interactions between
epithelial, stromal and immune cells were preserved and the
viability and responsiveness of the cells are verified. Using this
model, we investigated whether TWEAK influences the activities
of uNK cells by a modification of IL-18 expression or function.
Results
Validation of microhistoculture model
Cells morphology: The main problem we encountered with
endometrium in vitro histoculture was to maintain differentiated
cells and avoid they become fibroblastic. We analysed the
endometrium structure as well as the morphology of cells by
immunohistochemistry using two different antibodies: vimentin
(endothelial cells staining) and KL1 cytokeratin (epithelial cells
staining). We compared the morphology at different days of
culture with or without estradiol and progesterone addition
(50 nmol/l) and with or without use of collagen sponge (Figure 1).
In culture without sponge use, stromal cells are flat and
elongated (Figure 1C and D) compared to those cultured with
sponge which remained rounded (Figure 1E and F). But in both
case epithelial cells are dispersed. Cells cultured with estradiol and
progesterone (Figure 1G–J) displayed a well preserved morphol-
ogy, where epithelial cells maintain their polarisation. We realised
the same experience using endometrium biopsies from prolifera-
tive phase and observed the same results (data not shown). Thus,
to conserve their morphology endometrial cells must be cultured
on collagen sponge with hormones addition in medium.
Cells death: Cells viability was evaluated by immunohisto-
chemistry using Annexin V Fluos, an antibody coupled to FITC
(Figure 2). The Annexin V assay provides effective method to
detect apoptosis at a very early stage. After the induction of
apoptosis phosphatidylserine is translocated from the inner
(cytoplasmic) leaflet of the membrane to the outer (cell surface)
leaflet, phosphatidylserine on the outer leaflet is available to bind
labeled Annexin V, providing the basis for a simple staining assay.
After two days of culture we only observed Annexin V staining
on cells growing without collagen sponge matrix (Figure 2A and B)
compared to those culture with Gelfoam sponge (Figure 2C and
D). After five days, all cells cultured with or without sponge are
labeled (Figure 2E–H). Besides, after five days of culture without
sponge cells appeared elongated and fibroblastic whereas cells
growing with collagen sponge matrix are round.
We didn’t observe any difference on cells viability when we
added estradiol and progesterone in culture medium.
Cells functionality: We assay in supernatants, by Luminex
Technology, after 2 and 3 days of culture 8 cytokines and growth
factors: interleukine 1b (IL-1b), interleukine 1 receptora (IL-1Ra),
granulocyte colony stimulating factor (G-CSF), interferon induc-
ible protein-10 kilodaltons (IP-10), monocyte chemoattractant
protein 1 (MCP-1), macrophage inflammatory protein 1b
(MIP1b), platelet-derived growth factor b (PDGFb) and regulated
on activation of normal T cell expressed and secreted (RANTES).
These molecules were chosen as « markers » of endometrial
activity cells because their expression were different between
flushing with endometrial cells and flushing with no cells (data not
shown). We previously observed that addition of estradiol and
progesterone are suitable to maintain a well preserve structure of
epithelial cells. Our objective was to validate a model to study
expression or production of bio-molecules. So it was important to
determine whether estradiol and progesterone supplementation
influence cytokines or growth factors production.
We realised eight different conditions using 3 estradiol or
progesterone concentrations (50 nmol/l, 100 nmol/l, 200 nmol/l)
and a control condition without hormone. Cytokines and growth
factors production was assayed after 2 and 3 days of culture.
Because the cellular mass from endometrium sampling could not
be standardised, cytokine/growth factor production by day could
not be compared between individuals. So we chose to express our
results by the ratio day 3/day 2 cytokines production. This ratio
was measured by patients for each cytokine and each hormonal
concentration compared to control (without hormones). No
significant variation of cytokines and growth factors production
was observed according to distinct concentrations of estradiol or
progesterone or their comparison to control condition. Figure 3
represents the cytokine/growth factor production for minimal
concentration of estradiol and progesterone (50 nmol/l) for each
patient.
Role and regulation of TWEAK in endometrial cells
A minimal concentration (50 nmol/l) of estradiol and proges-
terone was added in each culture condition for all the experiments.
TWEAK and uNK Cytotoxicity
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NKp46. We compared the presence of the uNK cytotoxic
receptor, NKp46, in patients with an IL-18 over-expression (if
compared to the one observed in fertile patients) and either a low
or high mRNA TWEAK expression.
The NKp46 protein was mainly detectable in the luminal and
glandular epithelium and within the stroma around the spiral
arteries. The NKp46 immunostaining was stronger in patients
with IL-18 over-expression and simultaneously a low TWEAK
expression (Figure 4A) if compared with patients with IL-18 and
TWEAK over-expression (Figure 4B). No variation in staining
localisation was observed. Presence of TWEAK seems to control
the potential cytotoxic role of IL-18 on uNK cells, in case of over-
expression.
Does TWEAK regulate IL-18 or the opposite? We compared
the expression of TWEAK and IL-18 under different stimulation to
determine if TWEAK regulate IL-18 expression or be regulated by
this cytokine.
Stimulation of recombinant protein IL-18 or its antibody in the
culture medium did not influence subsequent TWEAK expression
if compared to the control condition. Only addition of ethanolate
as known inhibitor of the Map Kinase pathway induced a
Figure 1. Endometrium cells morphology providing from luteal phase. Revealed by immunohistochemistry with cytokeratin (KL1) and
vimentin antibodies (x 6,6). A–B: before culture, C–D: after 2 days of culture without hormones and without sponge, E–F: after 2 days of culture
without hormones and with sponge, G–H: after 2 days of culture with hormones (50 nmol/l estradiol +50 nmol/l progesterone) and without sponge,
I–J: after 2 days of culture with hormones (50 nmol estradiol +50 nmol progesterone) and with sponge.
doi:10.1371/journal.pone.0014497.g001
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Likewise, there was no variation of IL-18 expression after 24 h
of stimulation with recombinant TWEAK or its antibody in the
culture supernatant. As for TWEAK, only addition of ethanolate
produced an important IL-18 mRNA decrease (p=0.07)
(Figure 5B).
TWEAK expression is not regulated by IL-18 and IL-18 has no
effect on TWEAK mRNA. These results highlighted TWEAK
and IL-18 expression are independent one from the other in
human endometrium but are both regulated via a Map Kinase
pathway.
TWEAK and uNK cells. In order to verify whether TWEAK
could counterbalance IL-18 cytotoxic effect on uNK cells, we
quantified, in different culture conditions, the expression of two
proteins: NKp46, which mediates uNK cells cytotoxic effects and
TGF-b1 (Transforming Growth Factor–b) which promote the
angiogenic effect of uNK cells.
We added in culture media an excess of IL-18 recombinant
protein to create an endometrial pro-inflammatory environment in
all culture conditions. Excess of recombinant TWEAK protein or
its antibody was introduced in the medium too, in the aim to
modify IL-18 effects. Addition of TWEAK in the culture medium
had no effect on NKp46 or on TGF-b1 expression when
compared to the IL-18 basal over-expressed condition. However,
in TWEAK antibody supplemented culture medium, we observed
a significant increase of both NKp46 (Figure 6A) and TGF-
b1expression (Figure 6B). Only an imbalance between IL-18 and
TWEAK production has an impact on the two protein
expressions.
Discussion
We demonstrated, using a collagen sponge gel support with
hormonal substitution, that the endometrial cells are viable during
Figure 2. Endometrium cells death revealed by FITC-Annexin V antibody. A–D: after 2 days of culture, E–H: after 5 days of culture. A,E:
without sponge and without hormones, B,F: without sponge and with hormones (50 nmol/l estradiol +50 nmol/l progesterone), C,G: with sponge
and without hormones D,H: with sponge and with hormones (50 nmol/l estradiol +50 nmol/l progesterone).
doi:10.1371/journal.pone.0014497.g002
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endometrial ‘‘markers’’. Indeed, the cells conserved their morphol-
ogy and functionality even with a minimal hormone concentration.
Our model was very simple to use and we maintained interaction
between the different cellular types (epithelial, stromal, endothelial
and immunological cells). It seems to be a good system to study the
production or expression of cytokines and growth factors during the
window implantation in women. With this model we show that IL-
18 and TWEAK expression in endometrium are independent one
from the other but share the same way of regulation, the Map
Kinase pathway. However, as previously suggested, we confirmed
that TWEAK acts on the uNK cells cytotoxicity, induced by IL-18
over-expression, by modifying one of the uNK cells cytotoxic recep-
tor expression, NKp46.
The comprehensive functions of uNK cells still remain unclear. The
two possibilities that are currently under investigation are that uNK
cells influence maternal mucosal and arterial function [22] and/or
placental trophoblast invasion [23]. This assumption is further
supported by the high levels of angiogenic growth factor (Vascular
Endothelial GrowthFactorC, Placental Growth Factor, Angiopoietin-
1 and 2, Transforming Growth Factor -b) secreted by uNK cells from
both non-pregnant endometrium and early decidua [24].
In human, Laird et al observed an increased density of CD56
bright
(uNK cells) in mid luteal phase endometrium in women suffering
from recurrent implantation failures compared with fertile controls
[25] butdid not evaluate eithertheir cytotoxic potentialor cytokines
content. As we previously reported that high IL-18/TWEAK
endometrial mRNA expression correlated with a significant
increase of uNK cells recruitment, we investigated the role of these
two cytokines on uNK cells cytotoxicity. Manaster et al, reported
that both proliferative and secretory phase uNK cells express
NKp46 and NKG2D, but do not express NKp44 and NKp30, at
the opposite of NK cells from decidua which express high levels of
NKp30, NKp44 and NKG2D [26]. We then decided to choose
NKp46 as target to evaluate cytotoxicity of uNK cells in
endometrium. Our immunohistochemistry and PCR results show
that TWEAK doesn’t act on IL-18 expression, but seems to control
IL-18 related cytotoxicity on uNK cells when IL-18 is over-
expressed. Thus, TWEAK appears as a modulator to avoid
endometrial uNK cytotoxicity induced by IL-18 over-expression.
Besides we reported that TWEAK also influence TGF-b1
cytokine production, The biology of the TGF-b family is complex
and the various roles attributed to TGF-b in the uterus are still
unclear. Our results revealed that when IL-18 is over-expressed
and TWEAK is inhibited by a specific neutralising antibody, an
increase of TGF-b1 is observed. We postulated that the observed
TGF-b1 increase could reflect a retro-control loop; as TWEAK
could not protect anymore endometrial cells from inflammation,
others proteins with anti-inflammatory effect will be produced, like
TGF-b. Eriksson et al recently reports that endometrial production
of TGF-b regulate uNK cell proliferation but also cytokine
production and in particular the IFN-c production [27]. The
combined endometrial IL-18 over-expression with a TWEAK
inhibition increase cytotoxic receptors of uNK cells which produce
massively pro-inflammatory cytokines like IFNc. Local TGF-b are
produced to counterbalance the cytotoxic activities.
In summary, the present study presents IL-18 and TWEAK as
two independent proteins possibly acting in synergy to maintain
the angiogenic/cytotoxic balance related to uNK cells. Such data
should be controlled on larger number of patients. Taken together,
these results strengthen the idea that IL-18 on TWEAK mRNA
expression should be evaluated as functional biomarkers of an
adequate/inadequate uterine receptivity in order to detail the
mechanisms of failures.
Material and Methods
Patients
All patients provided informed consent and this investigation
was approved by our Institutional Review Board (CCPPRB). 30
Figure 3. Cytokine and growth factors measures in five different patients. The culture medium was supplemented with 50 nmol/l of
estradiol and progesterone. Proteins levels were measured on days 2 and 3. The graph represents for each protein the ratio of day 3 measure on day
2 measure, reported to the control condition. The control condition had no hormone addition. IL-1b and IL-Ra for patient 2 and PDGF for patient 5
were not detectable.
doi:10.1371/journal.pone.0014497.g003
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from North of Africa and 3 from Africa. All subjects were involved
in the Assisted Reproductive Technology program for investiga-
tions related to their infertility: 13 women experienced unex-
plained recurrent spontaneous abortion and 17 repeated and
unexplained implantation failure following in vitro fertilization
(IVF). They have no other remarkable pathological profile. 6
patients in this group had given birth to healthy infants. The
inclusion criteria included a normal hormonal reserve (FSH,10
mIU/ml) and patients were less than 38 years old (with a mean of
34,54).
8 patients were included to document NKp46 immunostaining:
all patients had a high IL-18 mRNA expression and either a low (4
patients) or a high (4 patients) TWEAK expression. 22 other
Figure 5. TWEAK (A) and IL-18 (B) mRNA expression. From endometrial microhistoculture in 9 patients. The control medium was only
supplemented with 50 nmol/l of hormones (estradiol and progesterone). Ethanolate was added to the medium as an inhibitor of Map Kinase
pathway. Estradiol and progesterone were added in all media.
doi:10.1371/journal.pone.0014497.g005
Figure 4. NKp46 immunostaining. Patients with an overexpression of IL-18 and with low (A) or high level of TWEAK (B). Magnification is 20X (first
column) and 40X (second column). ep: epithelium, s: stroma, gl: glands, sa: spiral arteries.
doi:10.1371/journal.pone.0014497.g004
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Individual analysis of each endometrial immune environment was
detailed as previously described [28] and showed either a normal
local uNK recruitment and activity or a cytokine–related uNK
depletion. None had a pro-inflammatory profile before the
microhistoculture in this group.
Endometrium Biopsy. Prior the endometrial biopsy, a
systematic endometrial ultrasonic examination was performed to
record the endometrial volume, exclude any intra-uterine
abnormality of the uterine cavity and document the overall
uterine vascularisation. As previously described [29,30,31], a
single operator (N.L.) employed an automated 5–9 MHz
transvaginal three-dimensional transducer (Voluson 730 expert,
GE Medical System, France) to acquire power Doppler
information from the uterus using identical settings and
technique in all cases as follows: tissue harmonic imaging, mild;
pulse repetition frequency, 0.6 khz; wall motion filter, low; gain,
27.8; high quality, rise 0.2. The volumetric and vascular
measurements were undertaken using the Virtual Organ
Computer-aided AnaLysis (VOCAL
TM, GE Kretz) imaging 4-D
VIEW program with the 15u rotation step. This allows the user to
define the volume of interest manually and applies a shell of
variable thickness that parallels the originally defined surface
contour, thus allowing delineation of the myometrial-endometrial
border. Intensity and quantity of the power signal was defined in
the sub-endometrial volume (endometrial volume +5 mm from the
Figure 6. NKp46 (A) and TGF-b (B) expression. From endometrial microhistoculture in 5 different patients. Recombinant human IL-18 (IL-18)
alone or with anti-human TWEAK (IL-18 + AC TW) were added to the medium. Estradiol and progesterone were added in all media.
doi:10.1371/journal.pone.0014497.g006
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during a monitored natural cycle 7 to 9 days after the ovulation
surge (LH) identified by serial blood tests. Biopsies were performed
with a standard Cornier pipelle (CCD Laboratories, Paris,
France). This method collects material from the superficial layer
and not the basal one, minimizing variations due to sampling from
different depths. One portion of the sample was embedded in
paraffin for immunostaining, another one was immediately placed
in a tube with RPMI 1640 Glutamax medium at 4uC for
endometrium histoculture. The last portion transferred into RNA
Stabilization Solution (RNA Later, QIAGEN, Courtaboueuf,
France) was used to quantify the basal level of TWEAK and IL-18
in fresh endometrium by real time PCR.
Endometrial Micro-histoculture
5 to 9 patients were included in each experiment and each
patient was her own control. The experiments were performed in
triplicate. During the 2–3 hours following collection, endometrium
biopsies were washed with RPMI 1640 medium. Collagen sponge
gels (1.5 cm
2, GelfoamH, Pharmacia Upjohn, Kalamazoo, MI,
USA) were placed into the wells of 12-well plates containing
1,5 ml per well of RPMI 1640 Glutamax medium supplemented
with 15% heat-inactivated fetal calf serum (FBS), 1% penicillin–
streptomycin, 1% non-essential amino acids, 1% sodium pyruvate
(Gibco BRL, Life Technologies, France). Endometrium were cut
into 1–2 mm blocks and placed on top of the collagen sponge gels
at the interface between the medium and the air (3 blocks per
collagen sponge and per well).
To validate the micro-histoculture model, four different
conditions were realised with or without collagen sponge gel and
with or without 50 nmol/l of b-estradiol and progesterone (Sigma,
France). Estradiol and progesterone were added to the medium
every day. Micro-histocultures were maintained at 37uC (5%
CO2). For the experiments, we used the collagen sponge gel with
50 nmol/l of b-estradiol and progesterone. Antibodies, recombi-
nant protein or inhibitors were added to the medium after
24 hours of culture. Biopsies pieces were collected after 24 hours
of incubation with the recombinant proteins, antibodies or
inhibitors and transferred into RNA Stabilization Solution (RNA
Later, QIAGEN, Courtaboueuf, France) to be stored at 280uC.
The RNA extraction was performed several days later. Recom-
binant human TWEAK (75 ng/ml), anti-human TWEAK
antibody (400 ng/ml), recombinant human IL-18 (100 ng/ml)
and anti-human IL-18 antibody (900 ng/ml) were from R&D
sytems (Lille, France). Ethanolate (5 mmol/l), an inhibitor of MAP
Kinase pathway was purchased from Sigma (St Quentin-Fallavier,
France).
Evaluation of cell death
The other part of micro-explants was placed into a well of 24
well plates with 1 ml of collagenase IV (1 mg/ml, Laboratoires
Eurobio, Courtaboeuf, France) during 2 hours at 37uC. The
dissociated cells were washed with PBS and incubated in a buffer
containing 500 ml Hepes and 10 ml Annexin V-Fluos (Roche
Diagnostics, Meylan, France) during 10 min at 37uC in darkness.
Cells were rinsed with Hepes and observed under a fluorescence
microscope. Dapi (49,6-diamidine-2-phenyl indole) was used to
stain nuclear cells (CML, Nemours, France).
Luminex
This experiment was realised using endometrial samples from 5
different patients. The culture medium was collected and fresh
medium was added on days 2 and 3. Medium was frozen at -20uC
until assay by the Luminex Technology (Bio-RadH). This
technology was used to simultaneously read concentrations of
IL-1b, IL-1RA, G-CSF, PDGF, IP-10, MCP-1, MIP-1b and
RANTES.The assay was performed according to the manufac-
turer’s instructions.
Total RNA extraction and reverse transcription
Endometrial fresh biopsy and micro-explants were disrupted in
the lysis buffer of a RNeasy kit (QIAGEN, Courtabeuf, France)
using an Ultra Turrax T15 (IKA-WERKE). Total RNA was
extracted using the RNeasy kit according to the manufacturer’s
instructions. Additional DNase digestion was performed during
the extraction process (RNase-free DNase set, QIAGEN, Courta-
beuf, France).RNA was stored at 280uC until use. Total RNA
(1 mg) was reversed transcripted into cDNA using random primers
and Superscript III (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions. Controls without reverse transcriptase
were systematically performed to detect genomic DNA contam-
ination. The cDNAs were stored at 220uC until use.
Real Time PCR
Specific primer for TWEAK [32], IL-18 [5], TGF-b1 [24] and
Ribosomal protein L13A (RPL13A) [33] were previously pub-
lished. Primers used for NKp46 (NKp46-s: gactagagagcgagccagca
and NKp46-as: aagagtctgtgtgttcagccttc) were designed using the
Universal Probe Library Assay Design Center (www.roche-
applied-science.com) and sequences were searched against Gen-
Bank sequences with the BLAST program to ensure the specificity
of primers. Real-time PCR was carried out using a LightCycler
480 apparatus (Roche, Meylan, France). Reactions were set up
using the following final concentrations: 0.5 mM of sense and
antisens primers, 1X 480 SYBER Green master mix and 4 mlo f
1/20 diluted cDNA. Cycling conditions were as follows:
denaturation (95uC for 5 min), amplification and quantitation
(95uC for 10 s, 60uC for 10 s and 72uC for 15 s) repeated 40 times,
a melting curve program (65–95uC with a ramp rate of 2,2uC/s)
and a cooling step to 4uC. In addition to the no-reverse
transcription and no-template controls, an independently inter-
run calibrator (IRC) was included in each RT-PCR assay. This
IRC was obtained from Blast-cells for TWEAK, TGF-b and
NKp46 and from placenta for IL-18, RPL-13.
In each assay, an aliquot of the IRC cDNA was 20 times diluted
and was submitted to the qPCR protocol as the unknown samples.
PCR efficiencies for each quantified target and reference were
calculated using known serial dilutions of each specific cDNA.
Data were analysed using the LightCyclerH480 Software release
1.5.0. Each specific target transcription level was normalized to the
geometric mean of the transcription levels of the reference gene,
using the Advanced Relative Quantification of the LightCy-
clerH480 Software. Each gene specific amplification efficiency was
specified. For each sample, results were expressed in concentration
ratio (target/reference mRNAs).
Immunohistochemistry
Micro-explants (on days 1 and 5) were fixed in 4% buffered
formaldehyde (96% Phosphate Buffer Saline or PBS) overnight at
4uC. They were washed with PBS, dehydrated in alcohol (70%,
95% and 100% ethanol) before being embedded in paraffin.
Paraffin sections (5 mm thick on Superfrost glass slides) were
deparaffined in histolemon and re-hydrated with alcohol.
Endogenous peroxydases and biotin activities were inhibited by
incubation of the slides in a specific solution (Peroxydase Blocking
solution, DAKO, Trappes, France and Avidin/Biotin Blocking
Vector kit, Abcys, Paris, France) or by incubation with 0.3%
hydrogen peroxide. Protein blocking was achieved by a 20 min
TWEAK and uNK Cytotoxicity
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serum and 5% human normal serum (blocking serum).
3 Morphological evaluation: Cytokeratin staining was made
using mouse anti-human cytokeratin pan KL1, dilution 1/40
(Clinisciences, Montrouge, France) and vimentin staining by using
mouse anti-human vimentin V9, dilution 1/200 (Biogenex,
France). KL1and vimentin immunostaining detection was per-
formed using the appropriated secondary antibody from kit
Vectastain (Vector ABC, Abcys, Paris, France) revealed with 3,39
diaminobenzidine (DAB, DAKO, Trappes, France).
3 NKp46 experiments: Physiological ranges of IL-18 and
TWEAK mRNA expression have been previously established in
control fertile women [28]. Briefly, TWEAK and IL-18 expression
were normalised using geometric mean of three validated
references genes (for the endometrium). We then calculated the
mean (+/2 SEM) of these ratio in our fertile patient group
allowing us to obtain the normal range both for IL-18 (3.8 to 6)
and TWEAK (4.2–6.5) mRNa expressions. We retrospectively
selected endometrial samples with a high IL-18 mRNA expression
(over 6.17) and low (below 4.1) or high TWEAK (over 6.86)
mRNA expression to compare their NKp46 and TGF-b protein
expression. NKp46 staining was made using a polyclonal goat
antihuman NKp46 antibody, concentration 4 mg/ml, (R&D
Systems, Lille, France). Between each steps the slides were rinsed
three times with PBS. NKp46 immunostaining detection was
performed using the appropriated secondary antibody from kit
Vectatstain (Vector ABC, Abcys, Paris, France) for 20 min
followed by incubation with a peroxydase-conjugated streptavidin
for 30 minutes and then by use of substrate buffer supplemented
with liquid DAB and hydrogen peroxide substrate solution
(DAKO, Trappes, France).
Counterstaining was performed with hematoxylin and slides
were mounted with Eukitt medium for light microscopy
observation. Negative controls were performed both by omission
of the primary antibody and by its replacement by an appropriate
isotype control. All slides were analysed with a fully automatic
virtual slide scanner (DotSlide BX micoscope, Olympus, Ham-
burg, Germany).
Statistical analysis
Wilcoxon test was used to compare production of cytokines and
growth factors (in different conditions of hormones concentration)
and TWEAK, IL-18, NKp46 and TGF-b1 mRNA expression in
each culture conditions. The statistical assessments were per-
formed using the StatView software (Abacus Concepts, Inc., CA,
USA). Significance was set up at p#0. 05.
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